Organization | Bucci Laser Vision Institute

Bucci Laser Vision Institute Report issue

Academic/Hospital Phase 4

Founded: Wilkes-Barre Pennsylvania United States (1998)

Organization Overview

First Clinical Trial

2006

NCT00347503

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Bucci Laser Vision | Bucci Laser Vision Institute | Bucci Vision Center | Frank A. Bucci, Jr., M.D.

Active Ingredients

Drugs in Phase 4 Trials (8)

besifloxacin (besivance) (2 trials)

bromfenac (xibrom) (4 trials)

dexamethasone (1 trial)

icosapent ethyl (vascepa) (1 trial)

ketorolac (acuvail) (5 trials)

lifitegrast (xiidra) (1 trial)

moxifloxacin (avelox) (2 trials)

nepafenac (nevanac) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Cataract (Phase 4)

Inflammation (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 10
# of Trial APIs: 8